ReviverX Inc.

About ReviverX Inc.

ReviverX is a biotechnology company developing mRNA-based therapies for age-related diseases. Its platform focuses on epigenetic reprogramming to restore youthful gene expression patterns, initially targeting fibrotic and neurodegenerative disorders. The company leverages modified mRNA molecules and lipid nanoparticle delivery systems to transiently express rejuvenation factors in vivo. Founded in 2021, ReviverX operates laboratories in San Diego and maintains research collaborations with academic institutions to advance clinical translation of its regenerative medicine pipeline.